SGPHealthcare

SpyGlass Pharma, Inc. Insider Trading Activity

Every SEC Form 4 insider transaction reported for SpyGlass Pharma, Inc. (SGP), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are SGP insiders buying or selling?

SpyGlass Pharma, Inc. insiders reported 15 open-market buys ($221.5M) and 0 sells ($0) across 15 Form 4 filings — a net buying position of $221.5M.

Source: SEC EDGAR Form 4

Key Statistics (as of Feb 11, 2026)

Total Form 4 filings
15
SEC EDGAR
Insider filers
15
Insider buys (15)
$221.5M
Insider sells (0)
$0

Insider sentiment

Net buying

Net insider flow of $221.5M in net buying.

Recent SGP insider transactions

DateInsiderRoleTypeSharesPriceValue
Feb 11, 2026Peter KolchinskyDirector, 10% OwnerPurchase3.7M$16.00$59.0M
Feb 11, 2026Ali BehbahaniDirector, 10% OwnerPurchase937.5K$16.00$15.0M
Feb 11, 2026Anthony A. Florence Jr.10% OwnerPurchase937.5K$16.00$15.0M
Feb 11, 2026Forest Baskett10% OwnerPurchase937.5K$16.00$15.0M
Feb 11, 2026New Enterprise Associates 17, L.P.10% OwnerPurchase937.5K$16.00$15.0M
Feb 11, 2026Rick Yang10% OwnerPurchase937.5K$16.00$15.0M
Feb 11, 2026Mohamad Makhzoumi10% OwnerPurchase937.5K$16.00$15.0M
Feb 11, 2026Scott D Sandell10% OwnerPurchase937.5K$16.00$15.0M
Feb 11, 2026Carmen Chang10% OwnerPurchase937.5K$16.00$15.0M
Feb 11, 2026Paul Edward Walker10% OwnerPurchase937.5K$16.00$15.0M
Feb 11, 2026Edward T Mathers10% OwnerPurchase937.5K$16.00$15.0M
Feb 11, 2026Geoffrey B PardoDirectorPurchase312.5K$16.00$5.0M
Feb 11, 2026Bilal Arshad KhanDirectorPurchase135.0K$16.00$2.2M
Feb 10, 2026Kirk G. NielsenDirectorPurchase165.0K$16.00$2.6M
Feb 10, 2026Kirk G. Nielsen10% OwnerPurchase165.0K$16.00$2.6M

Showing the 15 most recent of 15 Form 4 filings for SpyGlass Pharma, Inc..

Most active SGP insiders

  • Ali Behbahani1 filing
  • Anthony A. Florence Jr.1 filing
  • Bilal Arshad Khan1 filing
  • Carmen Chang1 filing
  • Edward T Mathers1 filing

Ask anything about SGP insider activity

Use Trabud's AI agent to query SpyGlass Pharma, Inc.'s Form 4 history in plain English — "Show me SGP CEO purchases this year" or compare it against any other ticker.

Open the AI agent

SGP insider trading FAQ

Are SpyGlass Pharma, Inc. insiders buying or selling?

Across 15 SEC Form 4 filings, SpyGlass Pharma, Inc. (SGP) insiders reported 15 open-market purchases totaling $221.5M and 0 sales totaling $0. That is a net buying position of $221.5M.

How many insiders trade SGP stock?

15 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for SpyGlass Pharma, Inc.. The most recent filing was accepted on Feb 11, 2026.

Where does Trabud get SGP insider trading data?

All SGP insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content